1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends

Oncology Market Access Europe – Payer and Industry Perspectives

  • July 2014
  • 75 pages
  • Firstword Pharma
Report ID: 2269979

Summary

Table of Contents




Oncology Market Access Europe – Payer and Industry Perspectives answers your questions:

What are payers looking for when making decisions regarding oncology reimbursement?
How are HTAs and other challenges affecting market access and what insight do payers offer?
How do payer decisions vary from market to market and what factors influence those decisions?
What will be the future role of real world data in payer decision-making?
What role do risk-sharing schemes, expanded access programmes and other pricing schemes play?
What factors should companies take into account when planning market access strategies?
Which innovations, such as PD-1 inhibitors, vaccines, personalised medicine and companion diagnostics show the most promise?



Oncology market access faces significant and mounting challenges as payers increase data requirements and financial austerity holds sway over decision-making. As pricing and reimbursement requirements become more stringent, issues of development cost, risk and slow market growth are at the forefront. In order to achieve market access success, companies need to adapt their approach and include health outcomes data to meet payer requirements.

Critical insight

Based on interviews and surveys with experts from the UK, Germany, Italy, France and Spain, FirstWord’s Oncology Market Access Europe – Payer and Industry Perspectives lays out the current – and growing – challenges facing companies in getting drugs to the European market. Filled with compelling insight into the most pressing issues ranging from changing payer data requirements and financial austerity to the adoption of formalised HTA, the report offers critical strategies, knowledge and a roadmap to the future.

A report for the whole industry

The challenges for oncology market access are expected to increase and grow in the near future, making Oncology Market Access Europe – Payer and Industry Perspectives a must-read report not only for those working in market access, brand strategy, business development and licensing, but in biosimilars, payer relationships and drug innovation.










Key benefits, features and insights

Oncology market access is evolving and requires constant updates to keep abreast of changes. In this report, stakeholders will:

Gain insight into both the industry and payer perspectives, with particular reference to the increasing importance of robust clinical health outcomes data
Understand the key issues affecting access and how they vary between markets
Learn about key strategies for success, such as patient access schemes, price-volume agreements and price capping
Identify what effective strategies are used by which companies and why they work
Understand why the industry needs to adapt to an evolving and challenging landscape
Gain insight into how market access issues are driving decisions around R&D

Key Features

Insight into the innovative strategies being employed to gain market access
Overview of new drug approvals and oncology pipeline prospects such as cancer vaccines, niche indications and personalised medicine
Examination of the role of HTAs from both payer and industry perspectives
Key findings regarding the importance of early inclusion of market access considerations

Key Insights

How oncology market access varies from country to country and why
Complete overview of current oncology market access trends and challenges
The payer perspective on everything from transparency in information to the use of health outcomes data in decision making
How payers view the HTA process and its role in the short to medium term



Key experts interviewed


UK payer: Deputy Head of Medicines Management for a PCT with regional and local funding and budgetary decision making responsibility
German payer: Head of a national budgetary committee with national, regional and local funding and budgetary decision making responsibility
Italian payer: Pharmacist involved in purchasing of drugs and devices for hospital and with national, regional and local funding and budgetary decision making responsibility
Spanish payer: Professor of health economics and advisor to the Ministry of Health on pricing and reimbursement issues, with national, regional and local funding and budgetary decision making responsibility
French payer – Hospital pharmacist involved in buying medical products including drugs and medical devices for a group of nine hospitals with regional and local funding and budgetary decision making responsibility
Former oncology marketing manager, BMS
Oncology marketing manager, GSK
Oncology medical manager, GSK
Oncology market access, Pfizer




Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Amrita helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Clinical Chemistry Reagents and Analyzers Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 75000
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. Please contact Client Services at reports@vpgcorp.com or +1 212 564 ...

Immunodiagnostics Analyzers and Reagents Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 75000
  • Industry report
  • July 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

Cancer Diagnostics Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Emerging Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 52400
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.